Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share of Common Stock (Details Narrative)

v3.23.1
Net Loss per Share of Common Stock (Details Narrative) - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 4,729,094 795,342
Committed Warrant [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Antidilutive securities including from computation of earnings per share, amount 3,160,130